This drug class confers benefits in diabetic patients with heart failure, CV disease, and renal disease, but it is also associated with major adverse events.
These severe epileptic encephalopathies manifest during early childhood, often causing severe neurologic, intellectual, and behavioral disorders that progressively worsen.